Company Monitoring Page for Amgen

job ratings (see below graph) for Amgen

latest headlines for company on cafepharma

Could Amgen soften the Neulasta biosimilar blow with an Alexion buy?
Fierce Pharma
Mon, 07/16/18 - 10:34 pm
Tags:
Amgen, biosimilars, Neulasta, Alexion, M&A
Amgen, UCB are back pitching once-rejected osteoporosis drug romo to the FDA — but big hurdles lie ahead
Endpoints
Fri, 07/13/18 - 11:57 am
Tags:
Amgen, UCB Pharma, osteoporosis, romosozumab
Amgen, Novartis 'overwhelmed' by early interest in migraine drug Aimovig: expert
Fierce Pharma
Wed, 07/4/18 - 10:01 am
Tags:
migraines, Amgen, Novartis, Aimovig
Amgen Announces Top-Line Data From Remicade Biosimilar Study
Yahoo/Zacks.com
Thu, 06/28/18 - 09:34 am
Tags:
Amgen, ABP 710, JNJ, Merck, Remicade, biosimilars, rheumatoid arthritis
Amgen's Repatha Reduces Bad Cholestrol in Type II Diabetes
NASDAQ.com
Tue, 06/26/18 - 09:47 am
Tags:
Amgen, Repatha, type 2 diabetes, diabetes, hypercholesterolemia, ADA
Akero picks up $65M to advance Amgen-licensed NASH drug
Fierce Biotech
Mon, 06/25/18 - 09:28 am
Tags:
Akeron Therapeutics, NASH, Amgen, AKR-001
Novartis touts effectiveness, safety of autoimmune drug copies
Yahoo/Reuters
Fri, 06/15/18 - 09:57 am
Tags:
Novartis, biosimilars, JNJ, Remicade, Amgen, Enbrel, autoimmune disease
Could an old Amgen-developed RA drug make CAR-T treatments safer?
Fierce Biotech
Thu, 06/7/18 - 10:08 am
Tags:
CAR-T, cytokine release syndrome, Kymriah, Yescarta, Amgen, Kineret
Migraine Breakthrough: Not So Fast
Forbes
Wed, 06/6/18 - 09:49 pm
Tags:
Amgen, Novartis, Aimovig, migraines, adults, monoclonal antibodies
Amgen's $3.9B Neulasta to face U.S. biosim 'in the coming weeks' with Mylan approval
Fierce Pharma
Tue, 06/5/18 - 12:02 pm
Tags:
FDA, Fulphila, Mylan Labs, biosimilars, Amgen, Neulasta
Amgen to ramp up early-stage immuno-oncology with 2 MD Anderson deals
Fierce Biotech
Sat, 06/2/18 - 02:33 pm
Tags:
Amgen, MD Anderson Cancer Center, drug development, blood cancers, Small-Cell Lung Cancer
FDA stalls yet another Herceptin copycat, issuing response letter to Amgen/Allergan
Endpoints
Fri, 06/1/18 - 10:40 pm
Tags:
Amgen, Allergan, FDA, complete response letter, biosimilars, Herceptin, ABP 980
ASCO Preview: Are Combo Treatments With Cancer-Killing Viruses Worth The Cost?
Forbes
Fri, 06/1/18 - 11:47 am
Tags:
Amgen, ASCO 2018, Imlygic
Thanks to lower-than-expected price, ICER backs Amgen's Aimovig—but only after other meds fail
Fierce Pharma
Fri, 06/1/18 - 11:40 am
Tags:
Amgen, ICER, Aimovig, migraines
With $460B in borrowing capacity, will any of the Big-20 biopharmas go after one of the top-5 takeover targets?
Endpoints
Tue, 05/29/18 - 09:22 pm
Tags:
M&A, JNJ, Merck, Pfizer, Gilead Sciences, Amgen, Biogen, Takeda, Regeneron, Alexion
Biopharma M&A: You Ain’t Seen Nothing Yet
Barron's
Fri, 05/25/18 - 09:32 am
Tags:
JNJ, Merck, Pfizer, Gilead Sciences, Amgen, Regeneron, Alexion, M&A
Up-and-coming Pfizer, AbbVie drugs set to threaten Amgen, Celgene: analyst
Fierce Pharma
Wed, 05/23/18 - 09:54 am
Tags:
Pfizer, Xeljanz, AbbVie, Upadacitinib, JAK inhibitors, Amgen, Enbrel, Celgene
Will Amgen’s migraine win and 5th thumbs-up for Prolia drive enough growth? Nope, says analyst
Fierce Pharma
Tue, 05/22/18 - 06:06 pm
Tags:
Amgen, FDA, Aimovig, migraines, Prolia
Amgen And Avalere Reports Reveal "Upside Down" Payer Biosimilar Realities
Biosimilar Development
Mon, 05/21/18 - 06:29 pm
Tags:
Amgen, Avalere, biosimilars, drug development, payers
Amgen, AbbVie 'ahead of the crowd' in fighting payers' latest assault on copay coupons
Fierce Pharma
Mon, 05/21/18 - 09:18 am
Tags:
copay coupons, Amgen, AbbVie, payers

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.